Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
Journal article published in 2017 by
Konstantinos Dimopoulos,
Alexandra Søgaard Helbo,
Helga Fibiger Munch-Petersen,
Lene Sjö,
Jesper Christensen,
Lasse Sommer Kristensen,
Fazila Asmar,
Niels Emil Ulrich Hermansen,
Casey O'Connel,
Peter Gimsing,
Gangning Liang,
Kirsten Grønbaek 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 